`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________________________
`
`
`
`
`WOCKHARDT BIO AG,
`Petitioner
`v.
`JANSSEN ONCOLOGY, INC.,
`Patent Owner
`____________________________
`
`Case IPR: 2016-01582
`U.S. Patent No. 8,822,438
`____________________________
`
`DECLARATION OF LESTIN L. KENTON JR.
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`-i-
`
`WCK1125
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`
`
`
`
`
`
`
`
`
`I, Lestin L. Kenton Jr., declare as follows:
`
`1.
`
`I am currently employed as an Associate Attorney at Sterne,
`
`Kessler, Goldstein & Fox P.L.L.C. I am more than twenty-one years of age, and I
`
`make this declaration based on my personal knowledge, experience, and belief.
`
`2. WCK116-1119, filed April 19, 2017, are references cited in the
`
`Reply Declaration of Ian McKeague, Ph.D. These exhibits were submitted with
`
`Petitioner’s Reply in IPR2016-01582 on April 19, 2017.
`
`3. WCK116, filed on April 19, 2017, is a true and correct copy of the
`
`American Cancer Society website page, “Hormone therapy for prostate cancer,”
`
`accessible at https://www.cancer.org/content/cancer/en/cancer/prostate-
`
`cancer/treating/hormone-therapy.html, last visited April 10, 2017. An exhibit label
`
`was added to this exhibit and no other alterations were made.
`
`4. WCK1118, filed on April 19, 2017, is a true and correct copy of
`
`the NIH National Cancer Institute website page, “Metastatic cancer,” accessible at
`
`https://www.cancer.gov/types/metastatic-cancer.html, last visited April 14, 2017.
`
`An exhibit label was added to this exhibit and no other alterations were made.
`
`5. WCK117, filed on April 19, 2017, is a true and correct copy of the
`
`NIH National Cancer Institute website page, “Prostate-specific antigen (PSA) test,”
`
`accessible at https://www.cancer.gov/types/prostate/psa-fact-sheet, last visited
`
`- 1 -
`
`WCK1125
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`
`
`
`
`April 11, 2017. An exhibit label was added to this exhibit and no other alterations
`
`
`
`
`
`were made.
`
`6. WCK1119, filed on April 19, 2017, is a true and correct copy of
`
`the Cougar Biotechnology, Inc., Clinical Study Report: COU-AA-001 and COU-
`
`AA-001 EXT dated November 17, 2010, accessible through https://clinical
`
`trials.gov. An exhibit label was added to this exhibit and no other alterations were
`
`made. WCK119 was obtained by (1) searching clinicaltrials.gov for the “COU-
`
`AA-001” study, (2) clicking on the first result, (3) scrolling down to the bottom of
`
`the page and clicking on the link provided under the “More Information” heading,
`
`(4) clicking on the URL provided, and (5) clicking on the downloaded PDF. See
`
`the following screenshots for a depiction of how WCK1119 was obtained:
`
`1:
`
`
`
`__________________________________________________________
`
`2:
`
`
`
`- 2 -
`
`WCK1125
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`
`
`
`
`
`
`
`3:
`
`
`
`
`
`__________________________________________________________
`
`4:
`
`
`
`__________________________________________________________
`
`5:
`
`
`
`7.
`
`I declare that all statements made herein of my own knowledge are
`
`true and that all statements made on information and belief are believed to be true;
`
`and further that these statements were made with the knowledge that willful false
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`under Section 1001 of Title 18 of the United States Code.
`
`
`
`
`
`
`
`Executed this 10th day of May 2017.
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Lestin L. Kenton Jr. (Reg No. 72,314)
`
`- 3 -
`
`WCK1125
`Wockhardt Bio AG v. Janssen Oncology, Inc.
`IPR2016-01582
`
`